Neurodevelopment in children with and without congenital heart block born to anti-Ro/SSA-positive mothers

Acta Paediatrica, International Journal of Paediatrics

Volumn 102, Issue 1, 2013, Pages 40-46

  Skog, Amanda ^a   Tingström, Joanna ^a   Salomonsson, Stina ^a   Sonesson, Sven Erik ^a   Wahren Herlenius, Marie ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Congenital heart block; Neonatal lupus erythematosus; neurodevelopment; Ro SSA autoantibodies; Systemic lupus erythematosus

Indexed keywords

BETAMETHASONE; PREDNISOLONE; RO ANTIBODY;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD; CONGENITAL HEART BLOCK; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; GESTATIONAL AGE; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE CELL DIFFERENTIATION; PREMATURITY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCHOOL CHILD; SCHOOL HEALTH SERVICE; SPEECH DISORDER; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; CHILD DEVELOPMENT; FEMALE; HEART BLOCK; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NERVOUS SYSTEM; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEINS;

EID: 84871019358     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12049     Document Type: Article

References (25)

1. Adelman DC, Saltiel E, Klinenberg JR,. The neuropsychiatric manifestations of systemic lupus erythematosus: an overview. Semin Arthritis Rheum 1986; 15: 185-99.
2. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, etal. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine 2004; 83: 280-91.
3. Ross G, Sammaritano L, Nass R, Lockshin M,. Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adol Med 2003; 157: 397-402.
4. McAllister DL, Kaplan BJ, Edworthy SM, Martin L, Crawford SG, Ramsey-Goldman R, etal. The influence of systemic lupus erythematosus on fetal development: cognitive, behavioral, and health trends. J Int Neuropsychol Soc 1997; 3: 370-6.
5. Lahita RG,. Systemic lupus erythematosus: learning disability in the male offspring of female patients and relationship to laterality. Psychoneuroendocrinology 1988; 13: 385-96.
6. Neri F, Chimini L, Bonomi F, Filippini E, Motta M, Faden D, etal. Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus 2004; 13: 805-11.
7. Lee JY, Huerta PT, Zhang J, Kowal C, Bertini E, Volpe BT, etal. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med 2009; 15: 91-6.
8. Wahren M, Solomin L, Pettersson I, Isenberg D,. Autoantibody repertoire to Ro/SSA and La/SSB antigens in patients with primary and secondary Sjögren's syndrome. J Autoimmun 1996; 9: 537-44.
9. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP,. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983; 309: 209-12.
10. Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M,. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002; 46: 1233-41.
11. Wahren-Herlenius M, Sonesson SE,. Specificity and effector mechanisms of autoantibodies in congenital heart block. Curr Opin Immunol 2006; 18: 690-6.
12. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, etal. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-5.
13. Saleeb S, Copel J, Friedman D, Buyon JP,. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999; 42: 2335-45.
14. Theander E, Brucato A, Gudmundsson S, Salomonsson S, Wahren-Herlenius M, Manthorpe R,. Primary Sjögren's syndrome-treatment of fetal incomplete atrioventricular block with dexamethasone. J Rehumatol 2001; 28: 373-6.
15. Friedman S, Shinwell ES,. Prenatal and postnatal steroid therapy and child neurodevelopment. Clin Perinatol 2004; 31: 529-44.
16. Silverman E, Jaeggi E,. Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immol 2010; 72: 223-5.
17. Yoshikawa N, Tanaka K, Sekigawa M, Kudo N, Arai Y, Ohtsuka Y, etal. Neurodevelopment in the offspring of Japanese systemic lupus erythematosus patients. Brain Dev 2010; 32: 390-5.
18. Askanase AD, Izmirly PM, Katholi M, Mumtaz J, Buyon JP,. Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus. Lupus 2010; 19: 300-6.
19. Behan WM, Behan PO, Geschwind N,. Anti-Ro antibody in mothers of dyslexic children. Dev Med Child Neurol 1985; 27: 538-40.
20. Salomonsson S, Dzikaite V, Zeffer E, Eliasson H, Ambrosi A, Bergman G, etal. A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block. Scand J Immol 2011; 74: 511-7.
21. Jongbloed-Pereboom M, Janssen AJ, Steenbergen B, Nijhuis-van der Sanden MW,. Motor learning and working memory in children born preterm: a systematic review. Neurosci Biobehav Rev 2012; 36: 1314-30.
22. Kadesjö B, Gillberg C,. Attention deficits and clumsiness in Swedish 7-year-old children. Dev Med Child Neurol 1998; 40: 796-804.
23. Gualtieri T, Hicks R, E,. An immunoreactive theory of selective male affliction. Sciences 1985; 8: 427-41.
24. Donofrio MT, Massaro AN,. Impact of congenital heart disease on brain development and neurodevelopmental outcome. Int J Pediatr 2010; 2010
25. Brucato A, Astori MG, Cimaz R, Villa P, Li Destri M, Chimini L, etal. Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero. Ann Rheum Dis 2006; 65: 1422-6.